This report found that in 2021, the sales of veterinary antibiotics decreased by 9.3% compared to 2020. Further reductions in the sales of veterinary antibiotics are expected in the coming years, as a result of Ireland’s second One Health national action plan on antimicrobial resistance for 2021-2025 and the new regulation on veterinary medicinal products (Regulation (EU) 2019/6) which introduces new controls on the authorisation, supply and use of veterinary antimicrobials.
This report presents the data collected by the HPRA for the year 2021, on the sales of veterinary antibiotics that are marketed in Ireland. This work is conducted in conjunction with the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project, a European Commission initiative coordinated by the European Medicines Agency (EMA) and with the assistance of the companies involved. The data are based on the voluntary declarations by marketing authorisation holders on the supply of their products. The HPRA has been collecting these data since 2009.
The sales data provided in this report should be interpreted with caution; annual sales figures have been observed to fluctuate and such variation is regarded as normal. It should be noted that changes in animal demographics from one year to the next will also influence the demand for antibiotics.